大理大学学报 ›› 2020, Vol. 5 ›› Issue (2): 72-75.DOI: 10. 3969 / j. issn. 2096-2266. 2020. 02. 016

• 临床医学 • 上一篇    下一篇

鲑鱼降钙素联合玻璃酸钠干预细胞因子的研究

李 超,赵剑波,何 宁,赵浩东,尹 坤 *   

  1. (大理大学第一附属医院,云南大理 671000)
  • 收稿日期:2019-01-02 修回日期:2019-01-26 出版日期:2020-02-15 发布日期:2020-02-15
  • 通讯作者: 尹坤,副主任医师,E-mail:dlfyyk@sohu.com。
  • 作者简介:李超,主治医师,主要从事骨外科研究。

Study on the Intervention of Cytokines by Salmon Calcitonin Combined with Sodium Hyaluronate

Li Chao, Zhao Jianbo, He Ning, Zhao Haodong, Yin Kun *   

  1. (The First Affiliated Hospital of Dali University, Dali, Yunnan 671000, China)
  • Received:2019-01-02 Revised:2019-01-26 Online:2020-02-15 Published:2020-02-15

摘要: 目的:探讨鲑鱼降钙素联合玻璃酸钠对膝关节骨性关节炎患者关节腔内滑液中细胞因子的影响。方法:抽取早中期膝
关节骨性关节炎患者80例,随机分为实验组及对照组,每组40例。实验组给予鲑鱼降钙素联合玻璃酸钠治疗,对照组仅给予
玻璃酸钠治疗。治疗前及治疗 3 个月后,运用酶联免疫吸附分析法(ELISA 法)测定两组关节腔滑液中白细胞介素 1β
(IL-1β)、白细胞介素6(IL-6)及基质金属蛋白酶-3(MMP-3)含量。结果:治疗前,两组滑液中IL-1β、IL-6及MMP-3含量差异无
统计学意义(P>0.05);治疗后,实验组滑液中IL-1β、IL-6及MMP-3含量较对照组明显降低,差异有统计学意义(P<0.05)。
结论:鲑鱼降钙素联合玻璃酸钠能降低关节腔内滑液中IL-1β、IL-6及MMP-3的含量,有望成为治疗骨性关节炎的新方法。

关键词: 鲑鱼降钙素, 玻璃酸钠, 骨性关节炎, 细胞因子

Abstract: Objective: To investigate the effect of salmon calcitonin combined with sodium hyaluronate on cytokines in synovial fluid
in patients with knee osteoarthritis. Methods: 80 patients with early and medial stage knee osteoarthritis were randomly divided into
the experimental group and the control group, with 40 cases in each group. The experimental group was treated with salmon calcitonin
and sodium hyaluronate, and the control group was only treated with sodium hyaluronate. Before and after three months of treatment,
the levels of synovial fluid IL-1β, IL-6 and MMP-3 in knee articular cavity of two groups were measured with ELISA. Results: Before
treatment, there were no significant differences in the levels of synovial fluid IL-1β, IL-6 and MMP-3 between the two groups(P>
0.05).After treatment, the levels of IL-1β, IL-6 and MMP-3 in the experimental group were significantly lower than those in the
control group, with statistically significant differences(P<0.05).Conclusion: After the treatment of salmon calcitonin and sodium
hyaluronate for osteoarthritis, the levels of synovial fluid IL-1β, IL-6 and MMP-3 in knee articular cavity could be decreased, so it
may be a new therapy in treating osteoarthritis.

Key words: salmon calcitonin, sodium hyaluronate, osteoarthritis, cytokines